期刊文献+

艾灵颗粒治疗HIV/AIDS患者19例临床总结 被引量:20

A report of clinical observation of 19 HIV/AIDS cases treated with a traditional drug named AiLing
下载PDF
导出
摘要 目的通过对应用艾灵颗粒治疗HIV感染者/AIDS患者前后疗效指标的对比,探讨中医药对艾滋病的疗效。方法给予19例HIV感染者/AIDS患者益气活血中药艾灵颗粒,疗程8个月,治疗前后记录症状体征积分,并检测体重、免疫功能、病毒载量、细胞因子、ALT和Cr。结果治疗后患者症状有明显改善,尤其是乏力、脱发的P值<0.05,症状总积分P值亦<0.05,有统计学意义。体重保持稳定。CD4总有效率57.89%,病毒载量总有效率84.21%,IL-2有增高趋势,但P>0.05尚未达到统计学意义。ALT、Cr治疗前后无明显变化。结论中药艾灵颗粒能显著改善HIV感染者/AIDS患者的临床症状,提高生存质量,并在一定程度上维护免疫功能,稳定病毒载量。 Objective To investigate the clinical efficacy of a traditional granule formulation named Ailing for the treatment of HIV/AIDS cases. Methods Ninteen HIV/AIDS cases were treated for a period of 8 months with AiLing, whose main function was to nourish qi and activate blood according to the theory of the traditional Chinese medicine During the treatment symptoms and weights of the patients were recorded,and their immune function, viral loads, cytokine, ALT, and Cr were tested. Results The symptoms of the treated patients, especially fatigue and baldness were reduced (P 〈 0.05). The total improvement rate of CD4 count was 57.89 % . The total effective rate of viral load was 84.21% , although IL-2 was not enhanced significantly.ALT,Cr and weight saw no change.Conclusion The granule AiLing could improve symptoms of the treated patients and enhance their quality of survival and could to certain extent maintain their immune functions and stabilize viral loads.
出处 《中国艾滋病性病》 CAS 2006年第2期105-107,共3页 Chinese Journal of Aids & STD
关键词 HIV感染者/AIDS患者 艾灵颗粒 治疗 HIV/AIDS Granule AiLing Treatment
  • 相关文献

参考文献6

  • 1周伟,危剑安,孙利民,黄霞珍,陈宇霞,宋春鑫.AIDS的高效抗逆转录病毒疗法的毒副作用[J].中国艾滋病性病,2005,11(1):73-75. 被引量:31
  • 2国家中医药管理局.中医药治疗艾滋病临床技术方案(试行)[S].2004.
  • 3国家中医药管理局中医药防治艾滋病工作组织协调小组办公室.11省中医药治疗艾滋病项目临床技术培训资料[C].2005.
  • 4Kamgal,Kahi S,Develioglu L,et al.Type Ⅰ Interferon Production Is Profoundly and Transiently Impaired in Primary HIV-1 Infection[J].Journal of infectious Diseases,2005,192(2):303 -311.
  • 5Marisa A Hong,Valeria L Wakim,Simone J Salomao,et al.IL-2 and (IFN-gamma),but not IL-4 secretion by peripheral blood mononuclear cells (PBMC) are related to CD4^+ T cells and clinical status in Brazilian HIV-1-infected subjects[J].Revista do Instituto de Medicina Tropical de Sao Paulo,1998,40(6):351-354.
  • 6贾谦.中医治疗艾滋病的疗效与前景[J].中国软科学,2005(5):21-24. 被引量:3

二级参考文献16

  • 1Corzo JE,Gomez-Mateos J,Rueda A.Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients[J].HIV Clin Trials,2003,4(5):337-346.
  • 2Shah SS,Rodriguez T,McGowan JP.Miller Fisher variant of Guillain-Barre syndrome associated with lactic acidosis and stavudine therapy.Clin Infect Dis[J].2003,36(10):131-133.
  • 3Montaner IS,Cote HC,Harris M.Mitochnodrial toxicity in the era of HA ART:evaluating venous lactate and peripheral blood mitochnodrial DNA in HIV-infected patients taking antiretr oviral therapy[J].J Acquir Immune Defic Syndr,2003,34 Suppl(1):S85-90.
  • 4Gerard Y,Viget N,Yazdanpanah Y.Hyperlactataemia during antiretrovir al therapy:incidences,clinical data and treatment[J].Therapie,2003,58(2):153-158.
  • 5Kontorinis N,Dieterich DT.Toxicity of non-nucleoside analogue reve rse transcriptase inhibitors[J].Semin Li ver Dis,2003,23(2):173-182.
  • 6Rhew DC,Bernal M,Aguilar D,et al.Association between protease in hibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus:a system atic review[J].Clin Infect Dis,2003,37(7):959-972.
  • 7Penzak SR,Chuck SK.Scand J Infect Dis,2000,32(2):111-123.
  • 8Graham NM.J Acquir Immune Defic Syndr,2000:25 (Suppl 1):S4-11.
  • 9McComsey G,Maa JF.Host factors maybe more important than choice of antiretrovirals in the development of lipoatrophy[J].AIDS Read,2003,13(11):539-542,559.
  • 10Chow DC,Souza SA,Chen R.Elevated blood pressure in HIV-infected individuals receiving highly active antir etroviral therapy[J].HIV Clin Trials,2003,4(6):411-416.

共引文献33

同被引文献259

引证文献20

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部